1969,
, although variation between assays, particularly at low hormone concentrations, precludes definite conclusions. Although basal gonadotrophin levels were low in our patients, there was a definite and equal FSH and LH response to the releasing hormone. Fetal gonadotrophins may have a role in sexual development in addition to chorionic gonadotrophins, and it may be relevant that in immature rats FSH has a permissive role for LH action (Odell et al. 1973 ). The possible role of low gonadotrophin secretion in the genesis of cryptorchidism in Kallmann's syndrome raises the question as to whether temporary or partial fetal gonadotrophin deficiency may be involved in other cases of cryptorchidism.
The biopsy of the cryptorchid testis of the 32year-old patient showed little sign of testicular hyalinization, which one usually expects in adult cryptorchid testes, even though he had had many years' replacement testosterone therapy. Although the increased temperature in the abdomen has been said to be the harmful factor (Johnston 1965 ) the undamaged testis in our patient suggests that the raised temperature may be harmful only in the presence of gonadotrophin secretion. Certainly cryptorchidism is usually thought to cause little damage in boys until about 8 years of age. The fibrosis of a few of the tubules in our patient may have been due to previous gonadotrophin therapy while the testes were cryptorchid. Three other reports have described adult cryptorchid Kallmann patients who have had biopsies, and do not mention testicular degeneration (Bardin et al. 1969 , Santen & Paulsen 1973 , Bell et al. 1973 ). In conclusion, it is possible that cryptorchidism in Kallmann's syndrome might be due to low fetal gonadotrophin secretion; further, probably because of the continuing low levels of gonadotrophin secretion, the testes do not undergo degeneration in adult life but remain potentially fertile. Abnormalities of connective tissue metabolism in diabetes have recently received increased attention (Spiro 1973) .
Skin Collagen in
Several conditions in which collagen is abnormal have been reported to be associated with an increased incidence of diabetes, including systemic sclerosis, Werner's syndrome and necrobiosis lipoidica. Most previous clinical studies on collagen in diabetes, either in man or in experimental animals, have concentrated on the small amount of total tissue collagen that is soluble. This communication presents our preliminary results in diabetics on changes in a polymeric collagen fraction that constitutes over 60% total skin collagen in controls.
Skin biopsies (85 mm2) were obtained from a standard site on the upper thigh of 38 control subjects (21 male, 17 female) with no evidence of connective tissue disease and three groups of patients with diabetes: (1) An untreated group (3 male, 3 female) with a mean duration of diabetes of less than six months. (2) A group (3 male, 3 female) treated with insulin. (3) A group (4 male, 4 female) treated with one of the sulphonylureas. Groups 2 and 3 had a mean duration of disease of 12 years.
Skin collagen was studied by the methods of Francis & Macmillan (1971) . These methods yield a collagen fraction, soluble in 5% NaCl, which constitutes less than 0.5 % of total collagen 'Requests for reprints may be sent to: Dr Julia P Ellis, Department of Dermatology, Radcliffe Infirmary, Oxford, OX2 6HE 
All results are given as means ±2 s.e.m. (no. of subjects) * Patients versus controls P < 0.001 -Patients versus controls P < 0.005 A Sulphonylurea versus insulin treated P < 0.001 X This index increases with polymeric collagen stability up to a maximum of 400 in controls and a polymeric collagen fraction that forms the bulk, over 600% in controls, of skin total collagen. The polymeric collagen fraction is composed of collagen molecules joined together by covalent chemical bonds. The introduction of these bonds is an important feature of the normal maturation of collagen in life and is responsible for many of the characteristic physiological and biochemical properties of mature connective tissue. The stability of polymeric collagen fractions to various depolymerizing agents yields an indirect measure of the number of those cross-links present in a sample (Francis et al. 1973) and has been estimated on the samples from control and diabetic patients.
Differences in collagen were found during the course of our studies. These appeared to be related to the treatment the patients were receiving and our results (see Table 1 ) have therefore been expressed in relation to therapy. For this reason too, in the analysis of the results, all patients who received both insulin and one of the sulphonylureas have been excluded. The significant increase in stability of the collagen of the diabetic group treated with sulphonylureas suggests that in this group the polymeric collagen is more cross-linked than normal.
Comment
Changes in the content of soluble collagen and of the stability of polymeric collagen have been detected in patients with diabetes. Both these changes may result from the increased levels in diabetics of the enzymes that glycosylate hydroxylysine, an amino-acid present uniquely in collagen (Spiro 1973) . The magnitude and direction of these changes appear to be related to treatment. We should emphasize that, as yet, only a small number of patients have been studied and that each group contains patients who vary both in the control and in the duration of their diabetes. Further studies are required to confirm that increased stability of polymeric collagen is a charac-teristic only of diabetic patients treated with the sulphonylureas and not related to some other aspect of their disease. If confirmed, our findings may be related to the conclusions drawn by the University Group Diabetes Program (1971) that the risk of cardiovascular complications in diabetics is increased in patients on the sulphonylureas.
Werner's Syndrome: Metabolic Observations by K G M M Alberti BM MRCPath, J D H Young MB FRCPEd and T D R Hockaday BM FRCP (Radcliffe Infirmary, Oxford) Case History J C, woman aged 26. Opthalmic examination, because of visual deterioration at age 25 showed posterior cortical cataracts bilaterally. Weight 44.5 kg, height 160 cm. She had bird-like facies, scanty subcutaneous fat, and unduly firm skin; grey hair had been present for two years. No skin lesions. Plasma urea, electrolytes, calcium and phosphate, liver function tests and hxematological examination all normal. X-rays revealed marked osteoporosis and trabeculation of the leg bones. Skin biopsy showed increased soluble collagen with polymeric collagen abnormally unstable for her age. (Dr Francis).
